Melbourne conference to examine better health through bio-chemistry

The latest research into the treatment of mental and behavioural disorders and autistic spectrum disorders will be discussed by experts in the field at the upcoming Walsh Research Institute Conference in Melbourne (Sunday 18th March, 2018).

The One Day Public Conference will be presented by Bio Balance Health at the Rendezvous Hotel in Melbourne, with six keynote speakers bringing expertise in the areas of mental health and behavioural disorders, biochemical imbalances, scientific research, autistic spectrum disorders, paediatrics, nutrition and molecular genetics.

The conference will be led by Dr. William J. Walsh, PHD, an internationally recognised expert on biochemical imbalances who has devoted nearly 40 years to researching the biochemistry behind behaviour, learning and memory, mental health and various disease conditions.

His early work included a 12 year collaboration with the renowned, late, Carl C. Pfeiffer, MD, PhD of Princeton, NJ (USA).

Dr. Walsh, the president of the non-profit Walsh Research Institute near Chicago, USA, has developed science-based, advanced nutrient therapies that have helped thousands of patients challenged by behavioural disorders, depression, anxiety, schizophrenia, ADHD, Autism and Alzheimer’s disease.

The author of more than 200 scientific articles and reports, Dr. Walsh has presented his experimental research at the American Psychiatric Association, The U.S Senate and National Institute of Mental Health and has been a speaker at 30 international conferences.

Dr. Walsh will discuss “Nutrient Therapy and Mental Illness - Present Capability and a Look at the Future.”

He will be joined by conference speakers Dr. Elizabeth Mumper, MD, FAAP; Dr. Nancy O’Hara, MD; Dr. Judith Bowman, MD; Dr. Stephanie Fryar-Williams, MB BS BSc (Biochem/Pharmacol) FRANZCP and Dr. Denise Furness, PHD (Hons) RNutr REPs. 

Dr. Elizabeth Mumper is President and CEO of Advocates of Children and Advocates for Families, devoted to the care of children with autism and other neurodevelopmental problems, and Founder of the Rimland Center in Virginia.

Dr. Mumper graduated magna cum laude from Bridgewater College and attended the Medical College of Virginia, did residency training at the University of Massachusetts and University of Virginia where she served as Chief Resident of Paediatrics at UVA.

She has published several research papers related to autism in the peer reviewed medical literature, and has chapters on allergy, immunology and behavioural developmental paediatrics published in “Paediatrics” a board review series book for medical students.

Dr. Mumper’s topic for discussion will include “Adventures in Brain Health: Research update from 2017.”

  • New publications about environmental factors affecting pregnancy and risk for autism and other chronic childhood conditions
  • Brain glymphatics: paradigm change about communication between the immune system and the brain
  • Cell danger response and the suramin trial at UCSD: promising avenues for intervention at the root cause of autism
  • ACE’s: Adverse Childhood Experiences and how we can promote resiliency in those affected

Dr. Judith Bowman, MD of Mensah Medical, joins Dr. Walsh as a trainer at the 2018 Walsh Research Institute training program for medical doctors – Mastering Brain Chemistry.

Answering the need for specialists with a background in both traditional as well as natural medicine, Dr. Bowman co-founded Mensah Medical with Dr. Albert Mensah, near Chicago in 2008, after serving as primary physicians at the original Pfeiffer Treatment Centre (now closed).

As one of the world’s leading biomedical practices specialising in biochemical individuality and imbalances, Mensah Medical has helped patients from all over the world and is recognised internationally for their metabolic treatment approaches for patients with autism, anxiety, depression, post-partum depression, behavioural and learning disorders, OCD, eating disorders, bipolar disorder, schizophrenia, Alzheimer’s disease and Parkinson’s disease.

Autism Spectrum Disorders represent 40 percent of Dr. Bowman’s patient population.

A faculty member of the Walsh Research Institute Medical Practitioner Training Program, Dr. Bowman utilises the foundational Walsh/Pfeiffer methodologies in a comprehensive fashion to heal the mind, body and soul of not only autistic patients, but their families as well.

Dr. Bowman will discuss “Biochemical approach to treat the symptoms of behavioural and cognitive disorders and autism spectrum disorder”.

A board certified paediatrician, Dr. Nancy O’Hara, MD, formerly taught children with autism. 

She graduated with highest honours from Bryn Mawr College and as a member of the Alpha Omega Alpha Honor Society from the University of Pennsylvania School of Medicine. She earned a Master’s degree in Public Health from the University of Pittsburgh.

After residency, chief residency and general paediatric fellowship at the University of Pittsburgh, Dr. O’Hara entered general private practice in 1993, and in 1998 began her consultative, integrative practice solely for children with special needs. Since 1999 she has dedicated her practice to the integrative and holistic care of children with neurodevelopment disorders, ADHD, PANDAS/PANS, OCD, Lyme and Autistic Spectrum Disorder. 

She is a leader in the training of clinicians, both in the US and abroad.

Dr. Nancy O’Hara will present POTS & PANS: A Review of Autoimmune Neuropsychiatric Syndromes and Associated Dysautonomia.

“Paediatric Autoimmune Neuropsychiatric Disorders associated with Streptococcal Infections, or PANDAS, is a common autoimmune disorder with far-reaching movement, behavioural, and cognitive consequences. While OCD and tics are still common, other issues like anxiety, bedtime fears, inability to control urination, aggression, and deficits in learning, attention, and social interaction are among the many manifestations that result from PANDAS/PANS and impair the daily functioning and cognitive progress for many children. Not only Strep, but Lyme, Viruses, Mycoplasma and other triggers can lead to Autoimmune Encephalitis. Autoimmune Encephalitis and PANDAS/PANS can also lead to significant dysautonomia, including POTS (Postural Orthostatic Tachycardia Syndrome). Heightened clinical suspicion and more appropriate and comprehensive treatment for both disorders with antibiotics and immune-modulating therapy will transform these devastating illnesses into treatable disorders.”

Dr. Stephanie Fryar-Williams is a Child, Adolescent and Adult Neuro-psychiatrist who undertook the Mental Health Biomarker Project – stage 2 (2010-2017). 

She did this as an Honorary Research Fellow at the University of Adelaide and Director of Youth-In-Mind Research Institute, South Australia via Basil Hetzel Institute for Translational Health Research and the Queen Elizabeth Hospital, Woodville South Australia.

Her research investigates ways that will assist clinicians to predict and confirm the diagnosis of schizophrenia and schizoaffective disorder.

This involves the discovery of biomarkers that reveal psychosis as the combination of interlinked biochemical and auditory and visual processing disorders.

Dr. Fryar-Williams will discuss “Research that investigates the ways that will assist clinicians to predict and confirm the diagnosis of schizophrenia and schizoaffective disorder.”

Dr. Fryar-Williams will share her presentation with Martha Mack, B.B.Sc., Grad. Dip. Coun., MAPS, MANSA, BCN.

Martha is Director of Listen and Learn Centre, Balwyn, Victoria; an Honorary Fellow of the Melbourne University Graduate School of Education and an Adjunct Senior Lecturer in the School of Psychological Sciences of Monash University.

Martha will describe the “Assessment process for auditory sensory processing disorders that commonly accompany abnormal biochemistry results.”

Dr. Denise Furness is a molecular geneticist, registered nutritionist and fitness instructor.

She conducted her PhD at CSIRO Human Nutrition and postdoctoral fellowship with the University of Adelaide investigating folate nutrigenomics, methylation and DNA damage in relation  to pregnancy outcomes.

She has won various awards for her research and published her work in peer reviewed medical and nutrition journals.

In 2012 Denise shifted from an academic research position to a consulting role, founding “Your Genes and Nutrition” helping patients and practitioners understand the role of nutrigenomics and genetic testing in relation to various health outcomes.

In particular, her focus is on the diagnosis and treatment of underlying triggers such as inflammation, oxidative stress, environmental pollutants and methylation.

Denise regularly presents at conferences and conducts educational seminars and workshops discussing the links between our genes and our environment and how these impact on our health throughout all the stages of the life cycle.

Dr. Furness will present “Nutrigenomics and genetic testing in relation to mental health conditions.”

The One Day Public Conference will run from 9.30am to 5pm (lunch break 12.30pm -2pm) and will include a Q and A panel of Australian doctors following the morning and afternoon guest speakers.

  • Professionals - $110 AUD including certificate
  • Public - $75 AUD 
  • Patients - $10 AUD ($10 concession fee only for Patients who have booked a one hour assessment at the 2018 Outreach) 

Register Online HERE, phone bookings 0475910513 or Email bookings: biobalance@optusnet.com.au

Review of Nutrient Power

“Nutrient Power” 

By Dr. William J Walsh

Published by Skyhorse Publishing Inc. 

Available through Walsh Research Institute website http://www.walshinstitute.org/

Just released, ‘Nutrient Power’ is a terrific read if you want to understand what makes a person tick – why they do the oddest things. He focuses on behaviour disorders - and their relationship to body chemistry. He looks at the mind-body connection – particularly with regard to mental disorders.

He carefully takes you through each mental disorder - depression, ADHD, Schizophrenia, autism, anxiety, behavioural disorders and others - dedicating an entire chapter to each one. For example did you know there are five different types of depression? Each type has its own chemistry and therefore needs its own specific nutrient supplementation. The good news is that his nutrient therapy can be administered at the same time as the anti-depressants – often with these medications being lowered and in many cases stopped altogether.

Dr Walsh then discusses his research on Alzheimer ‘s disease – and the chemistry behind it – and how there could be an answer for those people afflicted by it. Plus he looks at the field of epigenetics – how our genes are turned on and off – and how this can affect our vital organs like our brain, heart, skin etc. He postulates that the environment – either in utero or later in life - can over-ride our genetic imprint and how this can lead to the various mental disorders and many other diseases. Epigenetics is gaining popularity in medical research fields – but Dr. Walsh’s book gives an in depth discussion, understandable by the ordinary educated person, on this latest hot topic in science.

Although he has written the book for ‘doctors, medical researchers, and families afflicted by these diseases’ – and as such is scientifically based – it is a fascinating look at the science behind the mind- body connection. The basic premise is that if a person’s body chemistry is imbalanced, this can have a pronounced impact on what neurotransmitters their brain makes. These neurotransmitters dictate our behavioural patterns. Dr Walsh shows how such simple things as a copper imbalance can cause post-natal depression – for example. Altering these levels can cure such an affliction – even over-ride the genetic code or environmental toxins that causes the condition. Similarly there are three different biotypes for Schizophrenia, and numerous ADHD conditions. These are presented with case histories and the individualized nutrient therapies that have helped literally thousands of patients recover. In fact, Dr Walsh has treated over 1000 patients and trained over 90 doctors in Australia alone. 

Initally Dr. Carl Pfeiffer devised the program – called the Pfeiffer treatment - when he was researching Schizophrenia.  Since Dr. Pfeiffer’s demise, Dr. Walsh has taken over the research and broadened the field to include children with autism and varying disorders.   Dr Walsh’s initial research was based on violent behaviour of prisoners in the US.

Dr. Walsh clearly demonstrates how and why Psychiatry could gain a whole new direction – as individualized nutrients take over from psychiatric medications. These medications, he argues, “have nagging side effects” and “do not produce normalcy” of the brain.

 

Dr. Walsh is President of the Walsh Research Institute in USA and directs training programs for doctors and physicians in Australia, Norway and other countries. He has written 200 scientific papers and presented his research to the American Psychiatric Association, the US Senate, the National Institute of Mental Health, and has been a keynote speaker at 28 conferences. 

Tags: , ,

Alzheimers | Autism | Behavioural disorders | Depression | Schizophrenia

Nutrient Power, Epigenetics And Mental Health

by William J. Walsh, PhD

I’m pleased to announce that my new book NUTRIENT POWER (Skyhorse Publishing, Inc.) has been completed. The book won’t be released to Amazon and bookstores until September, but early copies are now available here

The book presents a science-based nutrient therapy system that can help millions of patients throughout the world. The text is aimed at doctors, researchers, and families challenged by depression, anxiety, schizophrenia, ADHD, autism, and other brain disorders. This approach recognizes that nutrient imbalances can alter brain levels of key neurotransmitters, disrupt gene expression of proteins and enzymes, and cripple the body’s protection against environmental toxins. 

The book demonstrates that depression, schizophrenia, and ADHD are umbrella terms that encompass disorders with widely differing brain chemistries and symptoms. Nutrient therapies tailored for five depression biotypes, three schizophrenia biotypes, and various ADHD conditions are presented along with several case histories. 

Other book highlights include the Walsh Theory of Schizophrenia, an epigenetic model of autism, a promising new Alzheimer’s treatment, and recommendations for reducing crime and violence. Individualized nutrient therapy treatments that have produced thousands of reports of recovery are presented along with several case histories. This modality is more scientific than trial-and-error use of psychiatric drugs, and is aimed at true normalization of the brain. More than 90 Australian physicians have been trained in this modality.

Epigenetics is a word unfamiliar to most Australians, but will soon be known to everyone. This emerging science is steadily revealing the causes of many of the world’s most challenging medical disorders, such as cancer and heart disease, and is providing a roadmap for development of vastly improved therapies. In an exciting development, new research indicates that many mental disorders also appear to be epigenetic in nature, and that improved treatments may be in the offing for schizophrenia, clinical depression, autism, ADHD, and criminal behaviour. Moreover, there is a good chance that these new therapies will be based on natural substances rather than drug medications. 

Epigenetics is a somewhat complicated subject and my book provides a detailed description of the processes involved and their impacts on brain function. There are more than a trillion cells in the human body, and each cell contains an identical copy of a person’s DNA. However, gene expression rates in brain, kidney, skin, heart and other tissues must be different for survival, and gene programming is established during the first few months of fetal development to accomplish this objective. In order to obtain the correct mix of enzymes and proteins in different organs, some genes are selectively “turned off” and others “turned on”. This process is called epigenetics, which means “above genetics”.

We are now learning that many diseases thought to be genetic are instead epigenetic in nature. The culprit is usually an environmental insult that alters gene expression “bookmarks” either in utero or later in life. Since deviant bookmarks can survive many cell divisions, the disorder doesn’t go away. There is considerable evidence that epigenetic errors are responsible for mental breakdowns experienced in schizophrenia, bipolar disorder, the sudden emergence of OCD, and the striking symptoms associated with regressive autism. It appears that deviant epigenetic bookmarks may be reversed by future therapies. In some cases, this could result in a permanent cure requiring no additional treatment. I hope epigenetics research aimed at mental disorders will become a major priority throughout the world.

My book asserts that today’s emphasis on prescription medications will not stand the test of time, and that the field of psychiatry needs a new direction. Psychiatric drugs suffer from a fundamental limitation – Introduction of foreign molecules that result in an abnormal condition rather than producing normalcy. Recent advances in epigenetics and the molecular biology of the brain have provided a roadmap for the development of effective, natural, drug-free therapies that do not produce serious side effects. An intensive research effort is needed to develop advanced epigenetic therapies that use chemicals natural to the body to normalize brain function, and thus avoid the nagging problem of drug side effects. Psychiatric medications have served society well over the past 50 years, but the need for drug therapies will gradually fade away as brain science advances. I believe we may be approaching a grand new era in the field of mental health. 

About the author:  Dr. William J. Walsh is president of the non-profit Walsh Research Institute in Illinois and directs physician-training programs in Australia, Norway, and other countries. Dr. Walsh has authored more than 200 scientific articles and reports and has five patents. He has presented his experimental research at the American Psychiatric Association, the U.S. Senate, the National Institutes of Mental Health, and has been a speaker at 28 international conferences. He has developed biochemical treatments for patients with behavioural disorders, ADHD, autism, depression, anxiety disorders, schizophrenia, and Alzheimer’s disease that are used by doctors throughout the world.

Tags: ,

ADD & ADHD | Autism | Depression | Schizophrenia